Carbapenem stewardship: positive impact on hospital ecology

Carbapenem stewardship: positive impact on hospital ecology

Show other versions (1)

INTRODUCTION: Excessive group 2 carbapenem use may result in decreased bacterial susceptibility. OBJECTIVE: We evaluated the impact of a carbapenem stewardship program, restricting imipenem and meropenem use. METHODS: Ertapenem was mandated for ESBL-producing Enterobacteriaceae infections in the abs...

Full description

Bibliographic Details
Main Authors:	Ana Lucia Lei Munhoz Lima, Priscila Rosalba Domingos de Oliveira, Adriana Pereira de Paula, Karine Dal-Paz, João Nóbrega de Almeida Jr, Cássia da Silva Félix, Flávia Rossi
Format:	Article
Language:	English
Published:	Elsevier
Series:	Brazilian Journal of Infectious Diseases
Subjects:	carbapenems drug resistance bacterial ecology
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702011000100001&lng=en&tlng=en

Similar Items

Carbapenem stewardship – positive impact on hospital ecology
by: Ana Lucia Lei Munhoz Lima, MD, PhD, et al.
Published: (2011-01-01)

Evaluation of carbapenem use in a tertiary hospital: antimicrobial stewardship urgently needed
by: Di Zhang, et al.
Published: (2019-01-01)

Carbapenem stewardship with ertapenem and antimicrobial resistance-a scoping review
by: Tiago Zequinão, et al.
Published: (2020-11-01)

Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem Resistant Gram-Negative Bacilli: An Interrupted Time-Series Analysis
by: Teresa López-Viñau, et al.
Published: (2021-05-01)

Long-Term Carbapenems Antimicrobial Stewardship Program
by: José Francisco García-Rodríguez, et al.
Published: (2020-12-01)

Antimicrobial Stewardship Programs: A Review of Strategies to Avoid Polymyxins and Carbapenems Misuse in Low Middle-Income Countries
by: Fabrício Rodrigues Torres de Carvalho, et al.
Published: (2022-03-01)

Piperacillin–tazobactam as alternative to carbapenems for ICU patients
by: Benoit Pilmis, et al.
Published: (2017-11-01)

An analysis of risk factors for carbapenem-resistant Enterobacteriaceae infection
by: Yan Gao, et al.
Published: (2022-09-01)

A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome
by: Claudia M. D. de Maio Carrilho, et al.
Published: (2016-11-01)

A case of swine flu superinfected with carbapenem resistant Klebsiella
by: Rajdip Hazra
Published: (2014-02-01)

Clinical and microbiological characteristics of diabetic foot infection by carbapenem-resistant bacteria in a hospital in southern Brazil
by: Stela Braun, et al.
Published: (2021-06-01)

Clinical and microbiological characteristics of diabetic foot infection by carbapenem-resistant bacteria in a hospital in southern Brazil
by: Stela Braun, et al.
Published: (2021-06-01)

Clinical and microbiological characteristics of diabetic foot infection by carbapenem-resistant bacteria in a hospital in southern Brazil
by: Stela Braun, et al.
Published: (2021-06-01)

The world-wide spread of carbapenem-resistant Enterobacterales
by: Arjana TAMBIC ANDRASEVIC, et al.
Published: (2021-04-01)

The world-wide spread of carbapenem-resistant Enterobacterales
by: Arjana TAMBIC ANDRASEVIC, et al.
Published: (2021-04-01)

Evaluating carbapenem restriction practices at a private hospital in Manila, Philippines as a strategy for antimicrobial stewardship
by: Kaitlin F. Mitchell, et al.
Published: (2019-07-01)

Does An Antimicrobial Stewardship Program for Carbapenem Use Reduce Costs? An Observation in Tehran, Iran.
by: Mahboubeh Hajiabdolbaghi, et al.
Published: (2020-05-01)

Antecedent carbapenem exposure as a risk factor for non-carbapenemase-producing carbapenem-resistant enterobacteriaceae and carbapenemase-producing enterobacteriaceae
by: Marimuthu, Kalisvar, et al.
Published: (2020)

Gram-negative osteomyelitis: clinical and microbiological profile
by: Vladimir Cordeiro de Carvalho, et al.

Effectiveness of a double-carbapenem combinations against carbapenem-resistant Gram-negative bacteria
by: Jiayue Lu, et al.
Published: (2022-06-01)

Genomic and Geographic Context for the Evolution of High-Risk Carbapenem-Resistant <italic toggle="yes">Enterobacter cloacae</italic> Complex Clones ST171 and ST78
by: Angela Gomez-Simmonds, et al.
Published: (2018-07-01)

Carbapenems in clinical practice
by: S.O. Kramarov, et al.
Published: (2019-03-01)

Carbapenem-Resistant Enterobacteria: How to Cope?
by: Füsun Zeynep Akçam
Published: (2019-06-01)

Evaluation and Identification of Carbapenem Resistant Klebsiella pneumoniae Isolated from Hospitalized Patients in Qom City, (Iran)
by: Syed Soheil Aghaei, et al.
Published: (2019-06-01)

Evaluation of Carbapenem Use Before and After Implementation of an Antimicrobial Stewardship-Led Carbapenem-Sparing Strategy in a Lebanese Tertiary Hospital: A Retrospective Study
by: Mira El Masri, et al.
Published: (2022-03-01)

Carbapenem triggers dissemination of chromosomally integrated carbapenemase genes via conjugative plasmids in Escherichia coli
by: Ryuichiro Abe, et al.
Published: (2023-06-01)

Carbapenem-Resistant Enterobacteriaceae among In-Patients of Tertiary Hospitals in Southwest, Nigeria
by: Ibikunle I. ANIBIJUWON, et al.
Published: (2018-09-01)

The Carbapenems Issue
by: David Sotello, et al.
Published: (2018-07-01)

Emergence of ST11-K47 and ST11-K64 hypervirulent carbapenem-resistant Klebsiella pneumoniae in bacterial liver abscesses from China: a molecular, biological, and epidemiological study
by: Qiwen Yang, et al.
Published: (2020-01-01)

New Delhi Metallo-β-Lactamase-Mediated Carbapenem Resistance: Origin, Diagnosis, Treatment and Public Health Concern
by: Wen-Juan Wei, et al.
Published: (2015-01-01)

Epidemiology of carbapenem-resistant Enterobacteriaceae: a 5-year experience at a tertiary care hospital
by: Chotiprasitsakul D, et al.
Published: (2019-02-01)

Prevalence and characterization of carbapenem‐resistant bacteria in water bodies in the Los Angeles–Southern California area
by: Dana E. Harmon, et al.
Published: (2019-04-01)

Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012–2015
by: Sandra N. Bulens, et al.
Published: (2018-04-01)

Epidemiological study of carbapenem-resistant Klebsiella pneumoniae
by: Lin Di, et al.
Published: (2018-10-01)

Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections
by: Matthew E. Falagas, et al.
Published: (2014-07-01)

Antimicrobial Prescribing before and after the Implementation of a Carbapenem-Focused Antimicrobial Stewardship Program in a Greek Tertiary Hospital during the COVID-19 Pandemic
by: Nikolaos Spernovasilis, et al.
Published: (2022-12-01)

Antimicrobial stewardship programme associated with earlier prescription of in vitro susceptible therapy and lower 14-day mortality in patients with carbapenem-resistant Enterobacterales bacteraemia: a cohort study
by: Andressa Barros, et al.
Published: (2022-03-01)

Activity of carbapenems and tigecycline against ESBL-producing Escherichia coli and Klebsiella spp.
by: Caio Fernando de Oliveira, et al.
Published: (2018-02-01)

Successful treatment of multidrug resistant Klebsiella pneumoniae using dual carbapenem regimen in immunocompromised patient
by: Wasim S. El Nekidy, et al.
Published: (2017-01-01)

Antimicrobial Stewardship Program for Patients in the Hematological Department Receiving Carbapenem Therapy: A Single-Center and Interrupted Time Series Analysis
by: Ayako Suzuki, et al.
Published: (2023-02-01)